Total Payments
$3,107
2024 Payments
$356.97
Companies
15
Transactions
184
Medicare Patients
1,411
Medicare Billing
$424,998
Payment Breakdown by Category
Food & Beverage$3,009 (96.9%)
Education$97.59 (3.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,009 | 181 | 96.9% |
| Education | $97.59 | 3 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $537.04 | 22 | $0 (2024) |
| ABBVIE INC. | $377.15 | 17 | $0 (2024) |
| Alkermes, Inc. | $368.63 | 24 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $366.04 | 26 | $0 (2020) |
| Lundbeck LLC | $292.66 | 17 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $254.60 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $240.57 | 17 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $172.21 | 10 | $0 (2023) |
| Allergan, Inc. | $143.97 | 8 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $129.52 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $356.97 | 17 | ABBVIE INC. ($93.68) |
| 2023 | $630.40 | 34 | AbbVie Inc. ($210.22) |
| 2022 | $300.91 | 13 | Teva Pharmaceuticals USA, Inc. ($139.23) |
| 2021 | $59.61 | 3 | AbbVie Inc. ($59.61) |
| 2020 | $156.60 | 9 | Neurocrine Biosciences, Inc. ($39.10) |
| 2019 | $679.32 | 42 | Teva Pharmaceuticals USA, Inc. ($175.01) |
| 2018 | $505.49 | 38 | Janssen Pharmaceuticals, Inc ($136.76) |
| 2017 | $417.41 | 28 | Sunovion Pharmaceuticals Inc. ($113.81) |
All Payment Transactions
184 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Neurology | ||||||
| 05/28/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.83 | General |
| Category: PSYCHIATRY | ||||||
| 05/07/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: CNS | ||||||
| 04/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: PSYCHIATRY | ||||||
| 04/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: PSYCHIATRY | ||||||
| 04/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2024 | Teva Pharmaceuticals USA, Inc. | — | Food and Beverage | In-kind items and services | $17.88 | General |
| 04/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: NEUROSCIENCE | ||||||
| 04/02/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.44 | General |
| Category: PSYCHIATRY | ||||||
| 03/19/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: CNS | ||||||
| 03/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $38.64 | General |
| Category: PSYCHIATRY | ||||||
| 02/27/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: PSYCHIATRY | ||||||
| 02/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: PSYCHIATRY | ||||||
| 02/13/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: CNS | ||||||
| 01/16/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: CNS | ||||||
| 12/19/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.82 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.42 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: CNS | ||||||
| 11/13/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Neurology | ||||||
| 10/31/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: CNS | ||||||
| 10/24/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Neuropsychiatry | ||||||
| 10/17/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 293 | 1,088 | $190,454 | $97,740 |
| 2022 | 5 | 331 | 1,162 | $190,241 | $102,236 |
| 2021 | 7 | 406 | 1,357 | $216,386 | $121,986 |
| 2020 | 5 | 381 | 1,234 | $176,858 | $103,036 |
Total Patients
1,411
Total Services
4,841
Medicare Billing
$424,998
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 420 | $87,810 | $37,755 | 43.0% |
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 79 | 304 | $58,805 | $34,699 | 59.0% |
| 90834 | Psychotherapy, 45 minutes | Office | 2023 | 66 | 162 | $21,950 | $12,706 | 57.9% |
| 90832 | Psychotherapy, 30 minutes | Office | 2023 | 50 | 186 | $15,534 | $10,819 | 69.6% |
| 90839 | Psychotherapy for crisis, first hour | Office | 2023 | 13 | 16 | $6,355 | $1,762 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 483 | $93,702 | $42,266 | 45.1% |
| 90837 | Psychotherapy, 1 hour | Office | 2022 | 84 | 319 | $56,761 | $35,568 | 62.7% |
| 90834 | Psychotherapy, 45 minutes | Office | 2022 | 83 | 176 | $21,814 | $13,016 | 59.7% |
| 90832 | Psychotherapy, 30 minutes | Office | 2022 | 55 | 135 | $10,663 | $7,361 | 69.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 20 | 49 | $7,301 | $4,025 | 55.1% |
| 90837 | Psychotherapy, 60 minutes | Office | 2021 | 76 | 344 | $60,259 | $37,920 | 62.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 87 | 336 | $63,699 | $32,247 | 50.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 73 | 256 | $38,234 | $22,302 | 58.3% |
| 90834 | Psychotherapy, 45 minutes | Office | 2021 | 59 | 198 | $24,197 | $14,618 | 60.4% |
| 90832 | Psychotherapy, 30 minutes | Office | 2021 | 75 | 176 | $13,844 | $9,700 | 70.1% |
| 90839 | Psychotherapy for crisis, first 60 minutes | Office | 2021 | 24 | 35 | $13,782 | $3,494 | 25.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 12 | 12 | $2,371 | $1,706 | 71.9% |
| 90837 | Psychotherapy, 60 minutes | Office | 2020 | 88 | 359 | $61,389 | $38,733 | 63.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 83 | 288 | $43,264 | $25,807 | 59.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 93 | 295 | $43,955 | $19,814 | 45.1% |
| 90834 | Psychotherapy, 45 minutes | Office | 2020 | 54 | 134 | $15,946 | $9,989 | 62.6% |
| 90832 | Psychotherapy, 30 minutes | Office | 2020 | 63 | 158 | $12,304 | $8,694 | 70.7% |
About Dr. Megan Carman, MD
Dr. Megan Carman, MD is a Psychiatry healthcare provider based in Franklin, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508975582.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Megan Carman, MD has received a total of $3,107 in payments from pharmaceutical and medical device companies, with $356.97 received in 2024. These payments were reported across 184 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($3,009).
As a Medicare-enrolled provider, Carman has provided services to 1,411 Medicare beneficiaries, totaling 4,841 services with total Medicare billing of $424,998. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Franklin, NH
- Active Since 08/30/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1508975582
Products in Payments
- VRAYLAR (Drug) $521.12
- LATUDA (Drug) $366.04
- AUSTEDO (Drug) $304.55
- REXULTI (Drug) $292.48
- INVEGA SUSTENNA (Drug) $218.55
- ARISTADA (Drug) $201.22
- INGREZZA (Drug) $172.21
- ABILIFY MAINTENA (Drug) $162.23
- Aristada 441 mg (Drug) $154.03
- CAPLYTA (Drug) $148.94
- Trintellix (Drug) $113.57
- TRINTELLIX (Drug) $88.28
- UZEDY (Drug) $64.76
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $36.71
- Auvelity (Drug) $22.32
- BRINTELLIX (Drug) $20.22
- Austedo XR (Drug) $18.10
- BELSOMRA (Drug) $16.35
- LYBALVI (Drug) $13.38
- SPRAVATO (Drug) $12.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Franklin
Sricharan Moturi, Md, MD
Psychiatry — Payments: $131,955
Psychiatry $131,955
Dr. James Hart, M.d, M.D
Psychiatry — Payments: $73,045
Psychiatry $73,045
Dr. William Bell, M.d, M.D
Psychiatry — Payments: $9,967
Psychiatry $9,967
Steven Nyquist, Md, MD
Psychiatry — Payments: $3,142
Psychiatry $3,142
Dr. Michael Ferri, M.d, M.D
Psychiatry — Payments: $2,921
Psychiatry $2,921
Dr. George Hardman, Md, MD
Psychiatry — Payments: $1,766
Psychiatry $1,766